Cytotoxic Effect of Doxorubicin on Human Multiple Myeloma Cells In Vitro

被引：2
作者：
Shushanov, S. S. [1 ]
Kravtsova, T. A. [1 ]
机构：
[1] Russian Acad Med Sci, Inst Carcinogenesis, NN Blokhin Canc Res Ctr, Moscow, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2013年 / 155卷 / 02期
关键词：
multiple myeloma; doxorubicin; insulin; gene expression; MULTIDRUG-RESISTANCE; GROWTH-FACTOR; INSULIN;
D O I：
10.1007/s10517-013-2120-6
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Cytotoxic effect of doxorubicin in human multiple myeloma cell cultures RPMI 1640, RPMI 8226, and IM-9 was studied. The obtained data were compared with mRNA expression of MDR1, MRP1, BCRP, LRP genes responsible for the development of multiple drug resistance. IM-9 cells that differed from the other two cultures by the expression of surface differentiation markers and by mRNA expression of MDR1, BCRP, and LRP were most sensitive to doxorubicin. All cells expressed mRNA for only A-isoform of insulin receptor (IRA), while B-isoform (IRB) was not expressed. Insulin in a concentration of 5 mu g/ml had no effect on the cytotoxic effect of doxorubicin in the studied cells.
引用
收藏
页码：228 / 232
页数：5
相关论文
共 50 条
  • [41] Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells
    Salzillo, Alessia
    Ragone, Angela
    Spina, Annamaria
    Naviglio, Silvio
    Sapio, Luigi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [42] A small-molecule inhibitor of RAD51 reduces homologous recombination and sensitizes multiple myeloma cells to doxorubicin
    Alagpulinsa, David A.
    Ayyadevare, Srinivas
    Reis, Robert Joseph Shmookler
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [43] Evaluation of potential cytotoxic and apoptotic effects of bioymifi on human multiple myeloma cell lines
    Terzi, Hatice
    Ergul, Merve
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (11) : 2363 - 2367
  • [44] Effect of levamisole on expression of CD138 and interleukin-6 in human multiple myeloma cell lines
    Nageshwari, B.
    Merugu, Ramchander
    INDIAN JOURNAL OF CANCER, 2017, 54 (03) : 566 - 571
  • [45] Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo
    Meng, Haitao
    Yang, Chunmei
    Ni, Wanmao
    Ding, Wei
    Yang, Xiudi
    Qian, Wenbin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (06) : 486 - 493
  • [46] Flunarizine Exhibits In Vitro Efficacy Against Lymphoma and Multiple Myeloma Cells
    Schmeel, Leonard Christopher
    Schmeel, Frederic Carsten
    Kim, Young
    Blaum-Feder, Sabine
    Endo, Tomoyuki
    Schmidt-Wolf, Ingo G. H.
    ANTICANCER RESEARCH, 2015, 35 (03) : 1369 - 1376
  • [47] iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
    Sara De Boo
    Joanna Kopecka
    Davide Brusa
    Elena Gazzano
    Lina Matera
    Dario Ghigo
    Amalia Bosia
    Chiara Riganti
    Molecular Cancer, 8
  • [48] Liposomal daunorubicin:: In vitro and in vivo efficacy in multiple myeloma
    Pratt, G
    Wiles, ME
    Rawstron, AC
    Davies, FE
    Fenton, JAL
    Proffitt, JA
    Child, JA
    Smith, GM
    Morgan, GJ
    HEMATOLOGICAL ONCOLOGY, 1998, 16 (02) : 47 - 55
  • [49] Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells
    Klippel, Steffen
    Jakubikova, Jana
    Delmore, Jake
    Ooi, Melissa
    McMillin, Douglas
    Kastritis, Efstathios
    Laubach, Jacob
    Richardson, Paul G.
    Anderson, Kenneth C.
    Mitsiades, Constantine S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (03) : 340 - 351
  • [50] Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro
    Buschauer, Sebastian
    Koch, Andreas
    Wiggermann, Philipp
    Mueller, Martina
    Hellerbrand, Claus
    ONCOLOGY LETTERS, 2018, 15 (04) : 4635 - 4640
12345